Anaptysbio ANAB
NASDAQ ANAB
$56.42 -1.04 (-1.81%)
As of: Sep 4, 2026 · 2:13 PM EDT

Anaptysbio (ANAB) Net Shares Issued and Repurchased (2025 - 2026)

Analysis

Anaptysbio (ANAB) Net Shares Issued and Repurchased (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.72 Bn 77.72 Bn 3.93 Bn -
3 Argenx Se 63.56 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.22 Bn 53.09 Bn 52.00 Mn -
5 Revolution Medicines 44.18 Bn 44.18 Bn - -
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.31 Bn 32.00 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.43 Bn 26.27 Bn 358.27 Mn -
10 Anaptysbio 1.62 Bn 1.34 Bn - 668,400.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 668,400.00
Dec 31, 2025 1.76 Mn